About
Prapela develops the SVS Bassinet Pad, a non-pharmacological medical device that delivers stochastic vibrotactile stimulation to treat neonatal opioid withdrawal syndrome (NOWS). The device received FDA De Novo authorization and is designed for use in hospital bassinets to support infant stabilization and reduce withdrawal severity alongside standard clinical protocols.
Explore Prapela's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.